We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+12.86%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$158M
AUM Growth
-$7.14M
Cap. Flow
-$21.7M
Cap. Flow %
-13.81%
Top 10 Hldgs %
5.64%
Holding
474
New
40
Increased
153
Reduced
231
Closed
49

Top Buys

Rank Stock Value
1
EXPE icon
Expedia Group
EXPE
+$752K
2
IT icon
Gartner
IT
+$681K
3
TT icon
Trane Technologies
TT
+$681K
4
ETN icon
Eaton
ETN
+$660K
5
PLD icon
Prologis
PLD
+$658K

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$854K
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$778K
3
IEX icon
IDEX
IEX
+$731K
4
TSLA icon
Tesla
TSLA
+$719K
5
YUMC icon
Yum China
YUMC
+$714K

Sector Composition

Rank Sector Weight
1 Healthcare 22.36%
2 Technology 15.51%
3 Financials 14.54%
4 Industrials 9.65%
5 Energy 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABUS icon
426
Arbutus Biopharma
ABUS
$847M
– –
-40,040
Closed -$81.3K
AJG icon
427
Arthur J. Gallagher & Co
AJG
$69.1B
– –
-3,415
Closed -$778K
ALB icon
428
Albemarle
ALB
$13.4B
– –
-3,459
Closed -$588K
ALDX icon
429
Aldeyra Therapeutics
ALDX
$97.1M
– –
-9,460
Closed -$63.2K
AMD icon
430
Advanced Micro Devices
AMD
$700B
– –
-6,731
Closed -$692K
ANSS
431
DELISTED
Ansys
ANSS
– –
-2,186
Closed -$650K
ARQT icon
432
Arcutis Biotherapeutics
ARQT
$3.48B
– –
-9,248
Closed -$49.1K
ATAI icon
433
AtaiBeckley Inc
ATAI
$2.66B
– –
-55,554
Closed -$71.7K
ATO icon
434
Atmos Energy
ATO
$29.7B
– –
-6,059
Closed -$642K
AVIR icon
435
Atea Pharmaceuticals
AVIR
$370M
– –
-24,183
Closed -$72.5K
BTAI icon
436
BioXcel Therapeutics
BTAI
$24.8M
– –
-290
Closed -$11.8K
CHWY icon
437
Chewy
CHWY
$9.54B
– –
-21,146
Closed -$386K
DSGN icon
438
Design Therapeutics
DSGN
$751M
– –
-18,313
Closed -$43.2K
ENTA icon
439
Enanta Pharmaceuticals
ENTA
$362M
– –
-12,784
Closed -$143K
ERAS icon
440
Erasca
ERAS
$6.15B
– –
-36,494
Closed -$71.9K
EWTX icon
441
Edgewise Therapeutics
EWTX
$4.28B
– –
-10,384
Closed -$59.5K
FATE icon
442
Fate Therapeutics
FATE
$275M
– –
-18,216
Closed -$38.6K
KYNB
443
Kyntra Bio
KYNB
$27.4M
– –
-241
Closed -$5.21K
GPC icon
444
Genuine Parts
GPC
$17.9B
– –
-4,778
Closed -$690K
HST icon
445
Host Hotels & Resorts
HST
$17.5B
– –
-42,510
Closed -$683K
HSY icon
446
Hershey
HSY
$37.3B
– –
-3,028
Closed -$606K
IEX icon
447
IDEX
IEX
$17B
– –
-3,513
Closed -$731K
KEYS icon
448
Keysight
KEYS
$50.7B
– –
-4,436
Closed -$587K
KOD icon
449
Kodiak Sciences
KOD
$2.5B
– –
-10,947
Closed -$19.7K
LLYVK icon
450
Liberty Live Group Series C
LLYVK
$9.54B
– –
-437
Closed -$14K
15 16 17
18
19

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, Virtus ETF Advisers held 474 positions worth $158M, down 4.3% from $165M the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Virtus ETF Advisers withdrew a net $21.7M in Q4 2023, closing 49 positions and reducing 231 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $854K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

Against the trend, Virtus ETF Advisers opened a new position in Expedia Group worth $932K.

  • Virtus ETF Advisers's largest Q4 2023 buy was Expedia Group: 6,139 shares worth $932K.
  • Virtus ETF Advisers added most to Pioneer Natural Resource Co. in Q4 2023, an estimated $535K increase.
  • Virtus ETF Advisers's biggest Q4 2023 reduction was VICI Properties, cutting an estimated $659K.
  • Virtus ETF Advisers fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $854K.
  • Virtus ETF Advisers's ten largest holdings make up 5.6% of its $158M portfolio in Q4 2023.
  • Virtus ETF Advisers opened 40 new positions and closed 49 in Q4 2023.
  • Virtus ETF Advisers's portfolio value fell 4.3% quarter-over-quarter to $158M.

Based on Virtus ETF Advisers's 13F filing for Q4 2023, filed 15 Feb 2024.